Multi-Cancer Blood Tests Spark Hope, but Evidence Is Still Lacking

Blood tests that search for multiple cancers by detecting circulating tumor DNA promise early detection, but a large UK trial showed many cancers were missed and negative results can give false reassurance; plus costs and false positives could strain health services. Traditional screening remains the proven approach for reducing deaths, though these tests may have a role in high‑risk groups or post‑treatment monitoring. They are not a magic bullet, and symptoms should still prompt medical advice; participate in trials or seek clear interpretation if such tests are offered privately.